Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides—Current Developments in Structure-Activity Relationship
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25137314 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Celia María Curieses Andrés und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Clínico Universitario of Valladolid, Avenida de Ramón y Cajal, 3, 47003 Valladolid, Spain. Hauptthemen laut MEDLINE: Antineoplastic Agents, Coordination Complexes, Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 261 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the State Plan for Scientific, Technical Research and Innovation 2021-2023 from the Spanish Min-istry of Science and Innovation, COCREA innovation project of the Spanish National Research Council (CSIC), State Plan for Scientific, Technical Research and Innovation 2021–2023 from the Spanish Ministry of Science and Innovation.
Abstract (Originalsprache)
This article provides an overview of the development, structure and activity of various metal complexes with anti-cancer activity. Chemical researchers continue to work on the development and synthesis of new molecules that could act as anti-tumor drugs to achieve more favorable therapies. It is therefore important to have information about the various chemotherapeutic substances and their mode of action. This review focuses on metallodrugs that contain a metal as a key structural fragment, with cisplatin paving the way for their chemotherapeutic application. The text also looks at ruthenium complexes, including the therapeutic applications of phosphorescent ruthenium(II) complexes, emphasizing their dual role in therapy and diagnostics. In addition, the antitumor activities of titanium and gold derivatives, their side effects, and ongoing research to improve their efficacy and reduce adverse effects are discussed. Metallization of host defense peptides (HDPs) with various metal ions is also highlighted as a strategy that significantly enhances their anticancer activity by broadening their mechanisms of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital Clínico Universitario of Valladolid, Avenida de Ramón y Cajal, 3, 47003 Valladolid, Spain.
- Institute of Natural Products and Agrobiology, CSIC-Spanish Research Council, Avda. Astrofísico Fco. Sánchez, 3, 38206 La Laguna, Spain.
- Cinquima Institute and Department of Organic Chemistry, Faculty of Sciences, Valladolid University, Paseo de Belén, 7, 47011 Valladolid, Spain.
- Sistemas de Biotecnología y Recursos Naturales, 47625 Valladolid, Spain.
ORCID-Profile: José Manuel Pérez de la Lastra, Celia Andrés Juan
Förderung
- the State Plan for Scientific, Technical Research and Innovation 2021-2023 from the Spanish Min-istry of Science and Innovation
- COCREA innovation project of the Spanish National Research Council (CSIC)
- State Plan for Scientific, Technical Research and Innovation 2021–2023 from the Spanish Ministry of Science and Innovation
Zitieren
APA
Andrés, C. M. C., Pérez de la Lastra, J. M., Bustamante Munguira, E., Andrés Juan, C., & Pérez-Lebeña, E. (2024). Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides—Current Developments in Structure-Activity Relationship. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137314
Vancouver
Andrés CMC, Pérez de la Lastra JM, Bustamante Munguira E, Andrés Juan C, Pérez-Lebeña E. Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides—Current Developments in Structure-Activity Relationship. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137314
BibTeX
@article{Andrs2024,
author = {Andrés, Celia María Curieses and Pérez de la Lastra, José Manuel and Bustamante Munguira, Elena and Andrés Juan, Celia and Pérez-Lebeña, Eduardo},
title = {Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides—Current Developments in Structure-Activity Relationship},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25137314}
}
EUVIMED